Mitotic progression is regulated largely by reversible phosphorylation events that are mediated by mitotic kinases and phosphatases. Protein phosphatase 1 (PP1) has been shown to play a crucial role in regulation of mitotic entry, progression, and exit. We previously observed, in Xenopus egg extracts, that phosphatase 1 nuclear targeting subunit (PPP1R10/PNUTS) acts as a mitotic regulator by negatively modulating PP1. This study investigates the role of PNUTS in mitotic progression in mammalian cells, and demonstrates that PNUTS expression is elevated in mitosis and depletion partially blocks mitotic entry. Cells that enter mitosis after PNUTS knockdown exhibit frequent chromosome mis-segregation. Aurora A/B kinase complexes and several kinetochore components are identified as PNUTS-associated proteins. PNUTS depletion suppresses the activation of Aurora A/B kinases, and disrupts the spatiotemporal regulation of the chromosomal passenger complex (CPC). PNUTS dynamically localizes to kinetochores, and is required for the activation of the spindle assembly checkpoint. Finally, PNUTS depletion sensitizes the tumor cell response to Aurora inhibition, suggesting that PNUTS is a potential drug target in combination anticancer therapy.

Implications:

Delineation of how PNUTS governs the mitotic activation and function of Aurora kinases will improve the understanding of the complex phospho-regulation in mitotic progression, and suggest new options to enhance the therapeutic efficacy of Aurora inhibitors.

Mitotic kinases, particularly cyclin-dependent kinase 1 (CDK1), polo-like kinase 1 (Plk1), and Aurora A/B, are well established as central regulators of mitosis. Activation of these kinases triggers the phosphorylation of various substrates to modulate all aspects of mitotic cell reorganization and progression (1–4). Thus, regulated activation and deactivation of these kinases are defined as molecular events that dictate M-phase entry and exit. Among mitotic kinases, Aurora A and Aurora B kinases phosphorylate a number of substrates to regulate the dynamics of centrosomes, microtubules, and chromatin during mitotic progression. Inactivation of Aurora A and B causes spindle defects, chromosome missegregation, cytokinesis failure, and aneuploidy (4–7). Owing to the crucial role of mitotic kinases in cell proliferation, and the profound toxicity of their inhibition, mitotic kinases are appreciated as potential drug targets for cancer therapy. Over the recent decade, numerous small-molecule inhibitors of Aurora kinases have been identified, and studies using these inhibitors demonstrated promising antitumor activities. Many of these inhibitors have entered clinical trials for breast cancer, prostate cancer, leukemia, and other malignancies (6, 8).

Protein phosphatases antagonize the action of kinases, but the function and regulation of mitotic phosphatases are considerably less studied (1, 2, 4, 9–12). The two major groups of serine and threonine phosphatases, protein phosphatase 1 (PP1) and 2A (PP2A), were both known to play important roles in mitotic regulation. For example, it has been shown that PP1 dephosphorylates numerous mitotic factors and thereby regulates mitotic entry, metaphase–anaphase transition, chromatin condensation, and mitotic exit (13–15). A major gap in knowledge, however, is how PP1 is regulated to achieve these dynamic and specific actions during mitotic progression.

Among the mitotic proteins dephosphorylated by PP1 were Aurora A and B kinases and their substrates, and the general role of PP1 as an antagonizer of Aurora kinases has been shown in multiple experimental systems (16–19). In yeast, the codeletion of PP1/Glc7 with Aurora/Ipl1 rescued mitotic progression and cell proliferation from Aurora/Ipl1 deletion (16). Similarly, PP1 suppression in mammalian cells prevented mitotic defects induced by the inhibition of Aurora B (17–19). The opposing relationship between PP1 and Aurora is perhaps best illustrated in the regulation of spindle assembly checkpoint signaling at kinetochores. The spindle checkpoint is a surveillance mechanism that ensures the proper, bipolar kinetochore–microtubule attachments (20, 21). It has been shown that reversible phosphorylation of kinetochore components plays a pivotal role in governing spindle attachment and the activation/deactivation of the spindle checkpoint (22). On one hand, centromeric Aurora B is responsible for the activation of the spindle checkpoint via both the recruitment of spindle checkpoint kinases, such as Mps1 and Bub1, and the subsequent phosphorylation of BubR1, Mad1, Ndc80/Hec1, Knl1, and other kinetochore proteins (21, 22). On the other hand, several kinetochore components, especially Knl1, yield PP1-binding activities, and were reported to recruit PP1 to kinetochores (19). After the proper spindle–kinetochore attachment, PP1 dephosphorylates Aurora B, Knl1, BubR1, and other kinetochore proteins to silence the spindle checkpoint and trigger metaphase–anaphase transition (22).

Phosphatase 1 nuclear subunit (PNUTS), also known as PPP1R10, was originally described as a nuclear regulator of PP1 that retains a portion of PP1 in the nucleus (23). PNUTS has been implicated in transcription and RNA processing (24, 25), DNA damage response and maintenance of telomere stability (26–30), and modulation of RB and PTEN (31–33). In most cases, with the exception of RNA Pol II, PNUTS acts to inhibit PP1 toward specific substrates. The earliest evidence that linked PNUTS to mitosis came from the observation that PNUTS enhanced the in vitro chromosome decondensation in a PP1-dependent manner (34). Interestingly, our recent study in Xenopus egg extracts suggested a role of PNUTS as an essential regulator of mitotic progression. Overexpression of PNUTS in Xenopus egg extracts inhibited mitotic exit. PNUTS depletion disrupted mitotic maintenance, whereas codepletion of PP1 rescued the defect (35). The level of PNUTS oscillated in cycling extracts and peaked in mitosis. In this study, we sought to examine the role of PNUTS in human cells, and to reveal further mechanistic insights into how PNUTS governs mitotic signaling. Our results confirmed a role of PNUTS in mammalian mitotic progression, characterized PNUTS-mediated regulation of Aurora kinases and spindle checkpoint signaling, and suggested PNUTS as a potential target to enhance the cytotoxicity of Aurora inhibitors.

Antibodies and other reagents

Cdc27 antibody was purchased from BD Transduction Laboratories; Aurora A, Aurora B, Bub1, Cenp-E, PP1, and PNUTS antibodies were purchased from Bethyl Laboratories; histone H3, phospho-H3 Ser-10, phospho-Aurora A/B/C, Aurora B, and β-actin antibodies were purchased from Cell Signaling Technology; PP1 antibody was purchased from Santa Cruz Biotechnology. PNUTS siRNA was obtained from Integrated DNA Technologies, with the targeting sequence of GGCGGCUACAAACUUCUU. PNUTS shRNA was generated using a pSUPER vector (Oligoengine), with the targeting sequence of CAGTGGTGGTTTCTGACAA.

Cell culture and treatment

Human cervix carcinoma (HeLa) cells, authenticated by ATCC, were maintained in DMEM (Hyclone) with 10% FBS (Hyclone). Breast cancer ZR75-1 and BT20 cells were authenticated at the University of Colorado Tissue Culture Core, and cultured in DMEM/F12 with 10% FBS. Cell-cycle synchronization at G1–S was performed using two rounds of thymidine treatment (at a final concentration of 2 mmol/L). For mitotic arrest, HeLa cells were treated with nocodazole (100 ng/mL) for 12 hours. Transfection was performed using Lipofectamine (Thermo Fisher Scientific), following a protocol recommended by the manufacturer.

Immunoblotting and immunoprecipitation

SDS-PAGE and immunoblotting were performed as described previously (36). For immunoprecipitation, anti-rabbit magnetic beads (New England Biolabs) were conjugated to the primary antibody, and then incubated in cell lysates for 2 hours. The beads were collected using a magnet, washed, eluted with Laemmli sample buffer, and then analyzed by immunoblotting.

Immunofluorescence and imaging

Immunofluorescence was performed as described previously (37). Briefly, cells were fixed in a fixation buffer (3% formaldehyde with 0.1% Triton X-100), washed, and blocked in a blocking buffer (10% goat serum in PBS). The primary antibodies were diluted in the blocking buffer, and incubated with the cells for 2 hours. The cells were then washed, and incubated with the Alexa Fluor 594 and 488 secondary antibodies (Invitrogen) for 1 hour. Imaging was performed using a Zeiss Axiovert 200M inverted fluorescence microscope at the UNMC Advanced Microscopy Core Facility. Live-cell imaging was performed using the Marianas Live Cell system based around a Zeiss Axiovert 200M microscope stand, and the SlideBook6 software (Intelligent Imaging Innovations, Inc.). Images were collected with 10× objective lens magnification. Once the live-cell microscopy was completed, the captured images were loaded into SlideBook Reader Software (Intelligent Imaging Innovations).

Protein expression, pull-down, and mass spectrometry analysis

MBP-tagged PNUTS was constructed and expressed as in our previous study (35). The recombinant protein was expressed in BL21 bacterial cells and purified on amylose beads. For the pull-down assay, amylose beads conjugated with MBP–PNUTS were incubated in Xenopus egg extracts that were prepared as in our previous study (35). The beads were reisolated, washed, eluted, and then resolved by SDS-PAGE for immunoblotting or mass spectrometry (Taplin mass spectrometry facility, Harvard Medical School, Boston, MA).

PNUTS regulates the mitotic progression of mammalian cells

To investigate the expression level of PNUTS during the cell cycle, HeLa cells were released into cell-cycle progression from thymidine arrest. Interestingly, PNUTS expression is strongly elevated in mitosis (Fig. 1A), consistent with our previous finding in Xenopus egg extracts (35). Compared with cyclin B1, which gradually accumulates prior to mitotic entry, PNUTS is more abruptly upregulated in M-phase (Fig. 1A). We then sought to examine the role of PNUTS in mammalian cell-cycle progression. siRNA-mediated PNUTS knockdown significantly reduced the percentage of mitotic cells (Fig. 1B and C), suggesting a role of PNUTS in mitotic entry. Consistently, a synchronized mitotic entry was not evident in cells treated with PNUTS siRNA, and then released from thymidine arrest (Fig. 1D). In addition to siRNA, the expression of PNUTS was also suppressed by shRNA, which targeted a distinct sequence of PNUTS (Fig. 1E). Real-time microscopy revealed blocked mitotic entry in cells expressing PNUTS shRNA (Fig. 1F). Moreover, although a smaller portion of cells with PNUTS knockdown still entered mitosis, they exhibited high levels of chromosome misalignment in metaphase and chromatin bridges in anaphase (Fig. 2A and B). Collectively, these lines of evidence demonstrated an important role of PNUTS in mitotic regulation.

Figure 1.

PNUTS is upregulated in mitosis and plays an essential role in mammalian mitotic progression. A, PNUTS upregulation in mitotic cells. HeLa cells were synchronized by thymidine arrest, and then released for 0 to 8 hours. Cells were harvested and analyzed by immunoblotting. B, HeLa cells were treated with control or PNUTS siRNA, and then analyzed by immunoblotting. C, PNUTS knockdown reduced mitotic entry. HeLa cells with control or PNUTS siRNA were stained with DAPI and analyzed microscopically. At least 1,000 cells in multiple fields were examined. Mitotic cells exhibiting condensed chromosomes and nuclear envelope breakdown were morphologically identified. The percentage of mitotic cells in control or PNUTS siRNA–treated cells was quantified. The mean value and SD were calculated from three independent experiments. Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.05 was considered statistically significant (*). D, HeLa cells were transfected with control or PNUTS siRNA. Thymidine release was performed as in A. Cells were harvested at the indicated time points, and analyzed by immunoblotting. The phosphorylation (band-shift) of Cdc27 indicates mitosis. E, HeLa cells were treated with PNUTS shRNA as described in Materials and Methods. The shRNA-expressing vector also contains a GFP-expressing cassette. As expected, the GFP-positive cell exhibits a lower level of PNUTS expression. F, PNUTS knockdown led to deficient mitotic entry. HeLa cells were treated with PNUTS shRNA as in E. These cells were synchronized by thymidine arrest and then released, as in A. Live cell imaging was performed as described in Materials and Methods to monitor mitotic progression. Representative images are shown. G, As in F, HeLa cells were released from thymidine arrest and analyzed by live cell imaging. Mitotic progression was monitored morphologically, as illustrated in F. The percentage of cells with mitotic entry within 10 hours is shown. At least 20 cells in multiple fields were examined. The mean value and SD were calculated from three independent experiments. Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.01 was considered statistically significant (**).

Figure 1.

PNUTS is upregulated in mitosis and plays an essential role in mammalian mitotic progression. A, PNUTS upregulation in mitotic cells. HeLa cells were synchronized by thymidine arrest, and then released for 0 to 8 hours. Cells were harvested and analyzed by immunoblotting. B, HeLa cells were treated with control or PNUTS siRNA, and then analyzed by immunoblotting. C, PNUTS knockdown reduced mitotic entry. HeLa cells with control or PNUTS siRNA were stained with DAPI and analyzed microscopically. At least 1,000 cells in multiple fields were examined. Mitotic cells exhibiting condensed chromosomes and nuclear envelope breakdown were morphologically identified. The percentage of mitotic cells in control or PNUTS siRNA–treated cells was quantified. The mean value and SD were calculated from three independent experiments. Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.05 was considered statistically significant (*). D, HeLa cells were transfected with control or PNUTS siRNA. Thymidine release was performed as in A. Cells were harvested at the indicated time points, and analyzed by immunoblotting. The phosphorylation (band-shift) of Cdc27 indicates mitosis. E, HeLa cells were treated with PNUTS shRNA as described in Materials and Methods. The shRNA-expressing vector also contains a GFP-expressing cassette. As expected, the GFP-positive cell exhibits a lower level of PNUTS expression. F, PNUTS knockdown led to deficient mitotic entry. HeLa cells were treated with PNUTS shRNA as in E. These cells were synchronized by thymidine arrest and then released, as in A. Live cell imaging was performed as described in Materials and Methods to monitor mitotic progression. Representative images are shown. G, As in F, HeLa cells were released from thymidine arrest and analyzed by live cell imaging. Mitotic progression was monitored morphologically, as illustrated in F. The percentage of cells with mitotic entry within 10 hours is shown. At least 20 cells in multiple fields were examined. The mean value and SD were calculated from three independent experiments. Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.01 was considered statistically significant (**).

Close modal
Figure 2.

PNUTS knockdown disrupts mitotic chromosome segregation. HeLa cells were treated with control or PNUTS siRNA for 24 hours, and analyzed microscopically for chromosome misalignment in metaphase (A) and anaphase bridge (B). The percentages of mitotic cells (N > 50) exhibiting these defects, and representative images (with DAPI stain) are shown. Misaligned chromosomes and anaphase bridges are marked by arrow heads. The mean value and SD were calculated from three independent experiments. Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.01 was considered statistically significant (**).

Figure 2.

PNUTS knockdown disrupts mitotic chromosome segregation. HeLa cells were treated with control or PNUTS siRNA for 24 hours, and analyzed microscopically for chromosome misalignment in metaphase (A) and anaphase bridge (B). The percentages of mitotic cells (N > 50) exhibiting these defects, and representative images (with DAPI stain) are shown. Misaligned chromosomes and anaphase bridges are marked by arrow heads. The mean value and SD were calculated from three independent experiments. Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.01 was considered statistically significant (**).

Close modal

PNUTS associates with Aurora kinases and kinetochore components

We speculated that PNUTS modulates the action of PP1 toward a subset of mitotic substrates. Thus, to reveal mechanistic insights into the specific function of PNUTS, we used mass spectrometry to identify proteins that copurified with PNUTS. Interestingly, the analysis identified Aurora A/Tpx2, Aurora B/Incenp complexes, and a number of kinetochore proteins, including Cenp-E and Bub1 (Fig. 3A; Supplementary Table S1). Immunoprecipitation in human cell lysates confirmed PNUTS association with Aurora A, Aurora B, Cenp-E, Bub1, and PP1 at the endogenous level (Fig. 3B). Consistently, the reciprocal immunoprecipitation of Aurora B recovered both PNUTS and PP1 (Fig. 3C).

Figure 3.

PNUTS associates with multiple mitotic regulators. A, As described in Materials and Methods, PNUTS pull-down was performed in Xenopus egg extracts that are particularly amenable for the biochemical isolation of large protein complexes, and analyzed by mass spectrometry to identify binding partners of PNUTS. The selected mitotic proteins and the number of identified peptides are shown. B, PNUTS immunoprecipitation (IP) was performed in HeLa cell lysates and analyzed by immunoblotting to confirm its association with Aurora A/B, Bub1, Cenp-E, and PP1. A control immunoprecipitation was performed using blank beads, and a 20% input lysate was included. C, Aurora B immunoprecipitation was performed in HeLa cell lysates and analyzed by immunoblotting to confirm its association with PNUTS and PP1. A control immunoprecipitation was performed using blank beads, and a 20% input lysate was included.

Figure 3.

PNUTS associates with multiple mitotic regulators. A, As described in Materials and Methods, PNUTS pull-down was performed in Xenopus egg extracts that are particularly amenable for the biochemical isolation of large protein complexes, and analyzed by mass spectrometry to identify binding partners of PNUTS. The selected mitotic proteins and the number of identified peptides are shown. B, PNUTS immunoprecipitation (IP) was performed in HeLa cell lysates and analyzed by immunoblotting to confirm its association with Aurora A/B, Bub1, Cenp-E, and PP1. A control immunoprecipitation was performed using blank beads, and a 20% input lysate was included. C, Aurora B immunoprecipitation was performed in HeLa cell lysates and analyzed by immunoblotting to confirm its association with PNUTS and PP1. A control immunoprecipitation was performed using blank beads, and a 20% input lysate was included.

Close modal

PNUTS modulates PP1-dependent dephosphorylation of Aurora A/B

Identification of Aurora A and B complexes as associated proteins of PNUTS prompted us to examine the potential role of PNUTS in regulation of Aurora kinases. It has been shown that PP1 antagonizes the functions of both Aurora A and Aurora B (14, 15, 22, 38). Interestingly, PNUTS blocked the PP1-dependent dephosphorylation of Aurora B kinase in a reconstitutive phosphatase assay (Fig. 4A and B). A similar impact of PNUTS on PP1-mediated dephosphorylation of Aurora A kinase was also observed (Fig. 4C). Moreover, the collection of mitotic cells with PNUTS knockdown exhibited lower levels of Aurora A and B activation, as judged by autophosphorylation (Fig. 4D). The deficient Aurora phosphorylation was rescued with reexpression of WT, but not W401A, PNUTS (Supplementary Fig. S1). Because the W401A mutation disrupts the PNUTS–PP1 association (24, 30, 35), our findings indicate that PNUTS modulates Aurora kinases in a PP1-dependent manner. Furthermore, immunofluorescent analysis of individual mitotic cells showed those that exhibited metaphase and anaphase defects due to PNUTS knockdown lacked efficient phosphorylation of Aurora A/B (Fig. 5A). Histone H3 Ser-10 is hyperphosphorylated in mitosis, mediated primarily by Aurora B (39). We observed that PNUTS depletion significantly lowered the level of H3 Ser-10 phosphorylation in metaphase and anaphase (Fig. 5B).

Figure 4.

PNUTS suppresses PP1-dependent inactivation of Aurora kinases. A, PNUTS prevents PP1-dependent dephosphorylation of active Aurora B. An in vitro phosphatase assay was performed using purified PP1, Aurora B, and PNUTS, as indicated. Samples were taken at the indicated time points and immunoblotted, as indicated. B, The PP1 phosphatase assay was performed as in A. The level of Aurora B phosphorylation was quantified using NIH ImageJ, and normalized to that of PP1. The mean value and SD were calculated from three independent experiments. Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.01 was considered significant (**). C, An in vitro phosphatase assay was performed using purified PP1, Aurora A, and PNUTS, as indicated. Samples were taken at the indicated time points and immunoblotted, as indicated. D, PNUTS knockdown reduced mitotic phosphorylation of Aurora A/B. HeLa cells with or without PNUTS siRNA were synchronized by thymidine block and released for 9 hours for mitotic entry. Mitotic cells were collected by shake-off and analyzed by immunoblotting.

Figure 4.

PNUTS suppresses PP1-dependent inactivation of Aurora kinases. A, PNUTS prevents PP1-dependent dephosphorylation of active Aurora B. An in vitro phosphatase assay was performed using purified PP1, Aurora B, and PNUTS, as indicated. Samples were taken at the indicated time points and immunoblotted, as indicated. B, The PP1 phosphatase assay was performed as in A. The level of Aurora B phosphorylation was quantified using NIH ImageJ, and normalized to that of PP1. The mean value and SD were calculated from three independent experiments. Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.01 was considered significant (**). C, An in vitro phosphatase assay was performed using purified PP1, Aurora A, and PNUTS, as indicated. Samples were taken at the indicated time points and immunoblotted, as indicated. D, PNUTS knockdown reduced mitotic phosphorylation of Aurora A/B. HeLa cells with or without PNUTS siRNA were synchronized by thymidine block and released for 9 hours for mitotic entry. Mitotic cells were collected by shake-off and analyzed by immunoblotting.

Close modal
Figure 5.

PNUTS knockdown disrupts the mitotic activation and localization of Aurora kinases. A, HeLa cells with control or PNUTS siRNA were analyzed by immunofluorescence for the phosphorylation of Aurora kinases. Misaligned chromosomes and anaphase bridges are marked by arrow heads. B, HeLa cells with control or PNUTS siRNA were analyzed by immunofluorescence for the phosphorylation of H3 Ser-10. Misaligned chromosomes and anaphase bridges are marked by arrow heads. C, HeLa cells with control or PNUTS siRNA were analyzed by immunofluorescence for Aurora B. Misaligned chromosomes and anaphase bridges are marked by arrow heads. D, As in C, 20 anaphase cells with either control or PNUTS knockdown were analyzed by immunofluorescence for Aurora B localization at either anaphase cell equator or anaphase chromosomes. Within the control and PNUTS siRNA–treated groups, cells were further classified into subgroups that exhibited either normal anaphase morphology or anaphase bridges. E, HeLa cells with control or PNUTS siRNA were analyzed by immunofluorescence for Incenp. Misaligned chromosomes and anaphase bridges are marked by arrow heads.

Figure 5.

PNUTS knockdown disrupts the mitotic activation and localization of Aurora kinases. A, HeLa cells with control or PNUTS siRNA were analyzed by immunofluorescence for the phosphorylation of Aurora kinases. Misaligned chromosomes and anaphase bridges are marked by arrow heads. B, HeLa cells with control or PNUTS siRNA were analyzed by immunofluorescence for the phosphorylation of H3 Ser-10. Misaligned chromosomes and anaphase bridges are marked by arrow heads. C, HeLa cells with control or PNUTS siRNA were analyzed by immunofluorescence for Aurora B. Misaligned chromosomes and anaphase bridges are marked by arrow heads. D, As in C, 20 anaphase cells with either control or PNUTS knockdown were analyzed by immunofluorescence for Aurora B localization at either anaphase cell equator or anaphase chromosomes. Within the control and PNUTS siRNA–treated groups, cells were further classified into subgroups that exhibited either normal anaphase morphology or anaphase bridges. E, HeLa cells with control or PNUTS siRNA were analyzed by immunofluorescence for Incenp. Misaligned chromosomes and anaphase bridges are marked by arrow heads.

Close modal

PNUTS depletion disrupts the mitotic localization of the chromosomal passenger complex

Upon metaphase-to-anaphase transition, the Aurora B–containing chromosomal passenger complex (CPC) relocates from anaphase chromosomes to the cell equator where it mediates mitotic exit (3, 4, 40). Interestingly, we observed altered localization of Aurora B in anaphase with PNUTS knockdown: in anaphase cells with PNUTS knockdown, Aurora B was trapped on chromosomes rather than being released to spindles at the cell equator (Fig. 5C). The dysregulation of Aurora B localization correlated with mitotic chromosome missegregation after PNUTS silencing (Fig. 5D). Moreover, a similar defect of INCENP localization was observed in PNUTS-depleted cells (Fig. 5E).

The spatiotemporal regulation of PNUTS in mitotic progression

The role of PNUTS in mitosis prompted us to ask how PNUTS itself is spatiotemporally modulated. As expected, PNUTS is exclusively localized in the cell nucleus in interphase. From late prometaphase to early telophase, the majority of PNUTS is removed from chromatin, with a small portion resides on spindles and poles (Supplementary Fig. S2). The reaccumulation of PNUTS on chromosomes begins in telophase (Supplementary Fig. S2), suggesting a potential involvement of PNUTS in the decondensation of mitotic chromosome. Moreover, consistent with the protein association of PNUTS with kinetochore proteins Cenp-E and Bub1 (Fig. 3), a portion of PNUTS colocalizes with kinetochore proteins in interphase cells, as marked by Cenp-E and ACA. However, PNUTS is delocalized from kinetochores in metaphase (Fig. 6A and B), indicating the dynamic dissociation of PNUTS from kinetochores.

Figure 6.

PNUTS colocalizes with kinetochores in a cell cycle–dependent manner, and is required for the activation of the spindle checkpoint. A, HeLa were analyzed by immunofluorescence for PNUTS and Cenp-E. Representative images of cells in interphase and mitosis (metaphase) are shown. B, HeLa were analyzed by immunofluorescence for PNUTS and ACA (anticentromere antibody). Representative images of cells in interphase and mitosis (metaphase) are shown. C, HeLa cells with or without PNUTS knockdown were analyzed by live-cell imaging for mitotic progression. The time from NEBD to anaphase onset was documented. The mean values and SD are shown (N = 20). Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.05 was considered statistically significant (*). D, HeLa cells were treated with nocodazole for 12 hours and analyzed with light microscope for mitotic index, as in Fig. 1C. The mean value and SD were calculated from three independent experiments. Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.001 was considered highly significant (***). E, PNUTS knockdown disrupts BubR1 phosphorylation induced by nocodazole. HeLa cells were treated with nocodazole and PNUTS siRNA as indicated, and analyzed by immunoblotting. F, PNUTS knockdown reduces the kinetochore localization of BubR1. HeLa cells with or without PNUTS siRNA were treated with nocodazole and analyzed by immunofluorescence for BubR1. Representative images of metaphase cells are shown.

Figure 6.

PNUTS colocalizes with kinetochores in a cell cycle–dependent manner, and is required for the activation of the spindle checkpoint. A, HeLa were analyzed by immunofluorescence for PNUTS and Cenp-E. Representative images of cells in interphase and mitosis (metaphase) are shown. B, HeLa were analyzed by immunofluorescence for PNUTS and ACA (anticentromere antibody). Representative images of cells in interphase and mitosis (metaphase) are shown. C, HeLa cells with or without PNUTS knockdown were analyzed by live-cell imaging for mitotic progression. The time from NEBD to anaphase onset was documented. The mean values and SD are shown (N = 20). Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.05 was considered statistically significant (*). D, HeLa cells were treated with nocodazole for 12 hours and analyzed with light microscope for mitotic index, as in Fig. 1C. The mean value and SD were calculated from three independent experiments. Statistical significance was analyzed using an unpaired two-tailed Student t test. P < 0.001 was considered highly significant (***). E, PNUTS knockdown disrupts BubR1 phosphorylation induced by nocodazole. HeLa cells were treated with nocodazole and PNUTS siRNA as indicated, and analyzed by immunoblotting. F, PNUTS knockdown reduces the kinetochore localization of BubR1. HeLa cells with or without PNUTS siRNA were treated with nocodazole and analyzed by immunofluorescence for BubR1. Representative images of metaphase cells are shown.

Close modal

PNUTS depletion attenuates the activation of the spindle checkpoint

The role of PNUTS in regulation of Aurora kinases, and the dynamic kinetochore-association of PNUTS suggest a role of PNUTS in kinetochore signaling and the activation of the spindle assembly checkpoint. Interestingly, PNUTS depletion accelerated the mitotic progression from nuclear envelope breakdown (NEBD) to the onset of anaphase (Fig. 6C). Moreover, PNUTS siRNA impaired metaphase arrest after nocodazole treatment (Fig. 6D), and diminished the phosphorylation and kinetochore localization of BubR1 (Fig. 6E and F). Together, these lines of evidence indicate a role of PNUTS in the activation of the spindle checkpoint.

PNUTS is a potential drug target to overcome the cancer resistance to Aurora inhibition

An important lesson learned from existing genetic and cellular studies is that, although Aurora kinases play important functions in mitosis, depletion of Aurora kinases can be well tolerated via downregulation of the counteracting PP1 (16–19). As we discovered PNUTS as a PP1-modulator toward Aurora kinases and their substrates, we speculated that PNUTS targeting would synergize with Aurora inhibition in conferring cytotoxicity. Interestingly, we observed that, compared with the treatment of an Aurora inhibitor, ZM447439, alone, the combination of PNUTS siRNA and ZM447439 more profoundly decreased the viability of breast cancer ZR75-1 cells (Fig. 7A). This breast cancer cell line was selected because it was previously shown to be resistant to Aurora kinase inhibition (41). Consistently, PNUTS siRNA and ZM447439 synergistically induce cell death (Fig. 7B). The synergistic effect between PNUTS siRNA and ZM447439 was also confirmed in BT20, another breast cancer cell line, and HeLa (Supplementary Fig. S3A and B).

Figure 7.

PNUTS targeting renders ZR75-1 breast cancer cells sensitive to Aurora inhibition. (A) ZR75-1 cells were treated with PNUTS siRNA and ZM447439 as indicated. The relative cell number (actual cell number/the starting cell number in day 1) is shown. The mean value and standard deviation were calculated from 3 independent experiments. Statistical significance was analyzed using one-way ANOVA and Turkey post hoc test. P < 0.001 was considered statistically significant (***). (B) ZR75-1 cells were treated with PNUTS siRNA and ZM447439, as indicated, for two days, and measured by the trypan blue exclusion assay for cell death. The mean value and standard deviation were calculated from 3 independent experiments. Statistical significance was analyzed using an unpaired 2-tailed Student t-test. P < 0.001 was considered highly significant (***).

Figure 7.

PNUTS targeting renders ZR75-1 breast cancer cells sensitive to Aurora inhibition. (A) ZR75-1 cells were treated with PNUTS siRNA and ZM447439 as indicated. The relative cell number (actual cell number/the starting cell number in day 1) is shown. The mean value and standard deviation were calculated from 3 independent experiments. Statistical significance was analyzed using one-way ANOVA and Turkey post hoc test. P < 0.001 was considered statistically significant (***). (B) ZR75-1 cells were treated with PNUTS siRNA and ZM447439, as indicated, for two days, and measured by the trypan blue exclusion assay for cell death. The mean value and standard deviation were calculated from 3 independent experiments. Statistical significance was analyzed using an unpaired 2-tailed Student t-test. P < 0.001 was considered highly significant (***).

Close modal

PNUTS modulates PP1 during mitotic progression

An evolutionarily conserved role of PP1 in mitotic regulation has been well established in yeast, Drosophila, Xenopus, and mammalian cells (14, 15, 42, 43). Mammalian PP1 exhibits dynamic and isoform-specific localization at kinetochores, centrosomes, chromosomes, and midbodies. Functionally, PP1 modulates the cell-cycle transitions of mitotic entry and exit, and controls various aspects of mitotic progression, including nuclear envelope assembly, kinetochore signaling and spindle checkpoint, chromosome architecture, and cytokinesis (14, 15, 42, 43). The complex functions of PP1 in mitosis rely on many targeting subunits that direct PP1 to specific mitotic substrates. For example, Repo-Man, KNL1, SKA, AKAP149, and Ki67 bind PP1, and recruit PP1 to anaphase chromosome, kinetochore, nuclear lamins, and other structures to govern mitotic progression (19, 43–47).

Interestingly, mitotic regulation of PP1 involves a number of mechanisms that negatively modulate PP1 activities. For example, PP1 is mitotically phosphorylated by CDK1, resulting in suppression of PP1 activity (48). Moreover, a specific inhibitor of PP1, inhibitor-1, binds PP1 during mitosis to reinforce PP1 inhibition (49). Another PP1 inhibitor, inhibitor-2, modulates the action of PP1 toward multiple mitotic kinases, including Nek2A, Aurora, A and Aurora B (18, 50, 51). Our previous study in Xenopus egg extracts suggested a role of PNUTS in the mitotic modulation of PP1 (35). In this study, we first confirmed the role of PNUTS in mammalian mitosis: PNUTS expression oscillates during the cell cycle and peaks in mitosis; PNUTS knockdown reduced mitotic entry, and induced severe chromosome missegregation. We then identified Aurora A, Aurora B-containing complexes, and several kinetochore proteins as specific binding patterns of PNUTS. PNUTS depletion suppressed the activation of Aurora A and Aurora B kinases, inhibited the relocalization of the Aurora B–containing chromosomal passenger complex from anaphase chromosomes to the cell equator, and bypassed the activation of the spindle checkpoint. Thus, our findings revealed a new mechanism involved in the inhibitory regulation of mitotic PP1. In particular, this mechanism is responsible for the efficient activation and function of Aurora kinases in mitotic progression. Although the experiments were primarily carried out in HeLa cells, owing to the high efficiency of siRNA transfection in these cells, a portion of the studies were confirmed in additional breast cancer cell lines. Moreover, the role of PNUTS in mitotic progression was first revealed in Xenopus egg extracts (35), indicating the well-conserved nature of this regulatory mechanism.

It remains a very intriguing question why the cell employs multiple distinct mechanisms to antagonize the activity of PP1 in mitosis. We speculate that the complex pattern of PP1 modulation is necessary to achieve the proper regulation of PP1 during mitotic progression. On one hand, the bulk of PP1 activity needs to be inhibited to allow the phosphorylation of mitotic substrates, which would otherwise be dephosphorylated by PP1. To this end, the antimitotic function of PP1 has been well established as an essential mechanism that promotes mitotic exit (42, 49). As an example, recent studies discovered a role of PP1 in the dephosphorylation of MASTL (also known as Greatwall kinase) during mitotic exit (36, 52–54). On the other hand, portions of PP1 bind specific mitotic structures and substrates, and play an active role in promoting several key steps of mitotic progression. For example, it has been shown that mitotic PP1 governs the proper microtubule–kinetochore attachment, silences the spindle checkpoint, and maintains the proper phosphorylation gradient and chromosome architecture (15, 42, 43). Interestingly, general inhibition of mitotic PP1 via overexpression of nuclear inhibitor of PP1 (NIPP1) in HeLa cells caused prometaphase arrest, spindle-formation and chromosome-congression defects, and hyperactivation of the spindle checkpoint (55). In principle, the involvement of multiple inhibitory mechanisms allows for the dynamic, localization-dependent, and substrate-specific modulation of PP1, although additional molecular details are needed to further delineate this model.

PNUTS mediates kinetochore signaling and spindle checkpoint activation

Our study revealed PNUTS association with kinetochore proteins, Cenp-E and Bub1. A portion of PNUTS colocalizes with Cenp-E and kinetochores in interphase, whereas PNUTS is excluded from kinetochores and chromosomes in metaphase. The dynamic kinetochore association and dissociation of PNUTS is potentially interesting. It is well recognized that reversible phosphorylation of kinetochore components plays a pivotal role in governing spindle attachment and the activation/deactivation of the spindle checkpoint. Several kinetochore components, especially Knl1, yield PP1-binding activities, and were reported to recruit PP1 to kinetochores (19). After the proper spindle–kinetochore attachment, PP1 dephosphorylates Aurora B, Knl1, BubR1, and other kinetochore proteins to silence the spindle checkpoint and trigger metaphase–anaphase transition (22). This switch-like, abrupt activation of PP1 may involve mechanisms that prevent the premature action of PP1. Thus, it is plausible that PNUTS plays a role in suppressing the premature activation of PP1, and that the kinetochore dissociation of PNUTS allows the timely activation of PP1 on kinetochores, which then triggers metaphase–anaphase transition. Further investigations are needed to better delineate the cell cycle–dependent kinetochore localization of PNUTS, as well as the detailed function of PNUTS in kinetochore signaling.

PNUTS is a potential drug target to overcome the resistance to Aurora kinase inhibition

Small-molecule inhibitors of Aurora kinases have been suggested as promising therapeutics for breast, ovarian, lung, and colon cancers, as well as hematologic malignancies (6, 8). Unfortunately, the clinical benefits of these therapeutic agents are often limited by drug resistance. Therefore, revealing mechanisms that allow cells to tolerate Aurora kinase inhibition is a crucial step toward development of strategies that overcome drug resistance. Interestingly, existing genetic and cellular studies showed that, although Aurora kinases play important functions in mitosis, depletion of Aurora kinases can be almost completely tolerated via downregulation of the counteracting PP1 (16–19). As we discovered PNUTS as a PP1-modulator toward Aurora kinases and substrates, we speculated that that mitotic modulation of PP1 by PNUTS may contribute to the cellular resistance to Aurora inhibition. We confirmed that PNUTS depletion sensitized resistant breast cancer cells to Aurora inhibition. Thus, it is plausible that PNUTS upregulation constitutes a mechanism of cancer resistance to Aurora inhibition. As such, PNUTS expression may serve as a prognostic indicator for Aurora resistance, and targeting PNUTS expression or its PP1 interaction, in conjunction with Aurora inhibition, may expand the therapeutic window, particularly in cancer cells that respond poorly to the current clinical inhibitors of Aurora kinases.

No potential conflicts of interest were disclosed.

Conception and design: F. Wang, A. Peng

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): F. Wang, L. Wang, L.A. Fisher

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): F. Wang, L. Wang, A. Peng

Writing, review, and/or revision of the manuscript: F. Wang, W. Wang, A. Peng

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): C. Li

Study supervision: C. Li, W. Wang, A. Peng

Microscopic analysis was performed at the UNMC Advanced Microscopy Core Facility, supported by the Nebraska Research Initiative, the Fred and Pamela Buffett Cancer Center support grant (P30CA036727), and an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the NIH (P30GM106397). This work was supported by NIH grant R01CA172574 to A. Peng.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1.
Nigg
EA
. 
Mitotic kinases as regulators of cell division and its checkpoints
.
Nat Rev Mol Cell Biol
2001
;
2
:
21
32
.
2.
Malumbres
M
,
Barbacid
M
. 
Cell cycle kinases in cancer
.
Curr Opin Genet Dev
2007
;
17
:
60
5
.
3.
Taylor
S
,
Peters
JM
. 
Polo and Aurora kinases: lessons derived from chemical biology
.
Curr Opin Cell Biol
2008
;
20
:
77
84
.
4.
Lens
SM
,
Voest
EE
,
Medema
RH
. 
Shared and separate functions of polo-like kinases and aurora kinases in cancer
.
Nat Rev Cancer
2010
;
10
:
825
41
.
5.
Dar
AA
,
Goff
LW
,
Majid
S
,
Berlin
J
,
El-Rifai
W
. 
Aurora kinase inhibitors–rising stars in cancer therapeutics?
Mol Cancer Ther
2010
;
9
:
268
78
.
6.
Bavetsias
V
,
Linardopoulos
S
. 
Aurora kinase inhibitors: current status and outlook
.
Front Oncol
2015
;
5
:
278
.
7.
Carmena
M
,
Earnshaw
WC
,
Glover
DM
. 
The dawn of aurora kinase research: from fly genetics to the clinic
.
Front Cell Dev Biol
2015
;
3
:
73
.
8.
Kollareddy
M
,
Zheleva
D
,
Dzubak
P
,
Brahmkshatriya
PS
,
Lepsik
M
,
Hajduch
M
. 
Aurora kinase inhibitors: progress towards the clinic
.
Invest New Drug
2012
;
30
:
2411
32
.
9.
Malumbres
M
,
Barbacid
M
. 
Mammalian cyclin-dependent kinases
.
Trends Biochem Sci
2005
;
30
:
630
41
.
10.
Ma
HT
,
Poon
RY
. 
How protein kinases co-ordinate mitosis in animal cells
.
Biochem J
2011
;
435
:
17
31
.
11.
Axton
JM
,
Dombradi
V
,
Cohen
PT
,
Glover
DM
. 
One of the protein phosphatase 1 isoenzymes in Drosophila is essential for mitosis
.
Cell
1990
;
63
:
33
46
.
12.
Ceulemans
H
,
Bollen
M
. 
Functional diversity of protein phosphatase-1, a cellular economizer and reset button
.
Physiol Rev
2004
;
84
:
1
39
.
13.
Moorhead
GB
,
Trinkle-Mulcahy
L
,
Ulke-Lemee
A
. 
Emerging roles of nuclear protein phosphatases
.
Nat Rev Mol Cell Biol
2007
;
8
:
234
44
.
14.
Bollen
M
,
Gerlich
DW
,
Lesage
B
. 
Mitotic phosphatases: from entry guards to exit guides
.
Trends Cell Biol
2009
;
19
:
531
41
.
15.
De Wulf
P
,
Montani
F
,
Visintin
R
. 
Protein phosphatases take the mitotic stage
.
Curr Opin Cell Biol
2009
;
21
:
806
15
.
16.
Francisco
L
,
Wang
W
,
Chan
CS
. 
Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation
.
Mol Cell Biol
1994
;
14
:
4731
40
.
17.
Emanuele
MJ
,
Lan
W
,
Jwa
M
,
Miller
SA
,
Chan
CS
,
Stukenberg
PT
. 
Aurora B kinase and protein phosphatase 1 have opposing roles in modulating kinetochore assembly
.
J Cell Biol
2008
;
181
:
241
54
.
18.
Wang
W
,
Stukenberg
PT
,
Brautigan
DL
. 
Phosphatase inhibitor-2 balances protein phosphatase 1 and aurora B kinase for chromosome segregation and cytokinesis in human retinal epithelial cells
.
Mol Biol Cell
2008
;
19
:
4852
62
.
19.
Liu
D
,
Vleugel
M
,
Backer
CB
,
Hori
T
,
Fukagawa
T
,
Cheeseman
IM
, et al
Regulated targeting of protein phosphatase 1 to the outer kinetochore by KNL1 opposes Aurora B kinase
.
J Cell Biol
2010
;
188
:
809
20
.
20.
Gruss
OJ
,
Vernos
I
. 
The mechanism of spindle assembly: functions of Ran and its target TPX2
.
J Cell Biol
2004
;
166
:
949
55
.
21.
Musacchio
A
. 
The molecular biology of spindle assembly checkpoint signaling dynamics
.
Curr Biol
2015
;
25
,
R1002
18
.
22.
Lesage
B
,
Qian
J
,
Bollen
M
. 
Spindle checkpoint silencing: PP1 tips the balance
.
Curr Biol
2011
;
21
,
R898
903
.
23.
Allen
PB
,
Kwon
YG
,
Nairn
AC
,
Greengard
P
. 
Isolation and characterization of PNUTS, a putative protein phosphatase 1 nuclear targeting subunit
.
J Biol Chem
1998
;
273
:
4089
95
.
24.
Kim
YM
,
Watanabe
T
,
Allen
PB
,
Lee
SJ
,
Greengard
P
,
Nairn
AC
, et al
PNUTS, a protein phosphatase 1 (PP1) nuclear targeting subunit
. 
Characterization of its PP1- and RNA-binding domains and regulation by phosphorylation
.
J Biol Chem
2003
;
278
:
13819
28
.
25.
Lee
JH
,
You
J
,
Dobrota
E
,
Skalnik
DG
. 
Identification and characterization of a novel human PP1 phosphatase complex
.
J Biol Chem
2010
;
285
:
24466
76
.
26.
Bounaix Morand du Puch
C
,
Barbier
E
,
Kraut
A
,
Coute
Y
,
Fuchs
J
,
Buhot
A
,
Livache
T
, et al
TOX4 and its binding partners recognize DNA adducts generated by platinum anticancer drugs
.
Arch Biochem Biophys
2011
;
507
:
296
303
.
27.
Landsverk
HB
,
Mora-Bermudez
F
,
Landsverk
OJ
,
Hasvold
G
,
Naderi
S
,
Bakke
O
, et al
The protein phosphatase 1 regulator PNUTS is a new component of the DNA damage response
.
EMBO Rep
2010
;
11
:
868
75
.
28.
Kim
H
,
Lee
OH
,
Xin
H
,
Chen
LY
,
Qin
J
,
Chae
HK
, et al
TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs
.
Nat Struct Mol Biol
2009
;
16
:
372
9
.
29.
Boon
RA
,
Iekushi
K
,
Lechner
S
,
Seeger
T
,
Fischer
A
,
Heydt
S
, et al
MicroRNA-34a regulates cardiac ageing and function
.
Nature
2013
;
495
:
107
10
.
30.
Zhu
S
,
Fisher
LA
,
Bessho
T
,
Peng
A
. 
Protein phosphatase 1 and phosphatase 1 nuclear targeting subunit-dependent regulation of DNA-dependent protein kinase and non-homologous end joining
.
Nucleic Acids Res
2017
;
45
:
10583
94
.
31.
Udho
E
,
Tedesco
VC
,
Zygmunt
A
,
Krucher
NA
. 
PNUTS (phosphatase nuclear targeting subunit) inhibits retinoblastoma-directed PP1 activity
.
Biochem Biophys Res Commun
2002
;
297
:
463
7
.
32.
Krucher
NA
,
Rubin
E
,
Tedesco
VC
,
Roberts
MH
,
Sherry
TC
,
De Leon
G
. 
Dephosphorylation of Rb (Thr-821) in response to cell stress
.
Exp Cell Res
2006
;
312
:
2757
63
.
33.
Kavela
S
,
Shinde
SR
,
Ratheesh
R
,
Viswakalyan
K
,
Bashyam
MD
,
Gowrishankar
S
, et al
PNUTS functions as a proto-oncogene by sequestering PTEN
.
Cancer Res
2013
;
73
:
205
14
.
34.
Landsverk
HB
,
Kirkhus
M
,
Bollen
M
,
Kuntziger
T
,
Collas
P
. 
PNUTS enhances in vitro chromosome decondensation in a PP1-dependent manner
.
Biochem J
2005
;
390
:
709
17
.
35.
Fisher
LA
,
Wang
L
,
Wu
L
,
Peng
A
. 
Phosphatase 1 nuclear targeting subunit is an essential regulator of M-phase entry, maintenance, and exit
.
J Biol Chem
2014
;
289
:
23745
52
.
36.
Ren
D
,
Fisher
LA
,
Zhao
J
,
Wang
L
,
Williams
BC
,
Goldberg
ML
, et al
Cell cycle-dependent regulation of greatwall kinase by protein phosphatase 1 and regulatory subunit 3B
.
J Biol Chem
2017
;
292
:
10026
34
.
37.
Peng
AM
,
Lewellyn
AL
,
Schiemann
WP
,
Maller
JL
. 
Repo-man controls a protein phosphatase 1-dependent threshold for DNA damage checkpoint activation
.
Curr Biol
2010
;
20
:
387
96
.
38.
Meadows
JC
. 
Interplay between mitotic kinesins and the Aurora kinase-PP1 (protein phosphatase 1) axis
.
Biochem Soc Transact
2013
;
41
:
1761
5
.
39.
Prigent
C
,
Dimitrov
S
. 
Phosphorylation of serine 10 in histone H3, what for?
J Cell Sci
2003
;
116
:
3677
85
.
40.
Carvajal
RD
,
Tse
A
,
Schwartz
GK
. 
Aurora kinases: new targets for cancer therapy
.
Clin Cancer Res
2006
;
12
:
6869
75
.
41.
Romanelli
A
,
Clark
A
,
Assayag
F
,
Chateau-Joubert
S
,
Poupon
MF
,
Servely
JL
, et al
Inhibiting aurora kinases reduces tumor growth and suppresses tumor recurrence after chemotherapy in patient-derived triple-negative breast cancer xenografts
.
Mol Cancer Ther
2012
;
11
:
2693
703
.
42.
Wurzenberger
C
,
Gerlich
DW
. 
Phosphatases: providing safe passage through mitotic exit
.
Nat Rev Mol Cell Biol
2011
;
12
:
469
82
.
43.
Rebelo
S
,
Santos
M
,
Martins
F
,
da Cruz e Silva
EF
,
da Cruz e Silva
OA
. 
Protein phosphatase 1 is a key player in nuclear events
.
Cell Signal
2015
;
27
:
2589
98
.
44.
Vagnarelli
P
,
Earnshaw
WC
. 
Repo-Man-PP1: a link between chromatin remodelling and nuclear envelope reassembly
.
Nucleus
2012
;
3
:
138
42
.
45.
Sivakumar
S
,
Janczyk
PL
,
Qu
Q
,
Brautigam
CA
,
Stukenberg
PT
,
Yu
H
, et al
The human SKA complex drives the metaphase-anaphase cell cycle transition by recruiting protein phosphatase 1 to kinetochores
.
eLife
2016
;
5
,
e12902
.
46.
Steen
RL
,
Martins
SB
,
Tasken
K
,
Collas
P
. 
Recruitment of protein phosphatase 1 to the nuclear envelope by A-kinase anchoring protein AKAP149 is a prerequisite for nuclear lamina assembly
.
J Cell Biol
2000
;
150
:
1251
62
.
47.
Booth
DG
,
Takagi
M
,
Sanchez-Pulido
L
,
Petfalski
E
,
Vargiu
G
,
Samejima
K
, et al
Ki-67 is a PP1-interacting protein that organises the mitotic chromosome periphery
.
eLife
2014
;
3
,
e01641
.
48.
Dohadwala
M
,
da Cruz e Silva
EF
,
Hall
FL
,
Williams
RT
,
Carbonaro-Hall
DA
,
Nairn
AC
, et al
Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases
.
Proc Natl Acad Sci U S A
1994
;
91
:
6408
12
.
49.
Wu
JQ
,
Guo
JY
,
Tang
W
,
Yang
CS
,
Freel
CD
,
Chen
C
, et al
PP1-mediated dephosphorylation of phosphoproteins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation
.
Nat Cell Biol
2009
;
11
:
644
51
.
50.
Satinover
DL
,
Leach
CA
,
Stukenberg
PT
,
Brautigan
DL
. 
Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein
.
Proc Natl Acad Sci U S A
2004
;
101
:
8625
30
.
51.
Eto
M
,
Elliott
E
,
Prickett
TD
,
Brautigan
DL
. 
Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation
.
J Biol Chem
2002
;
277
:
44013
20
.
52.
Heim
A
,
Konietzny
A
,
Mayer
TU
. 
Protein phosphatase 1 is essential for Greatwall inactivation at mitotic exit
.
EMBO Rep
2015
;
16
:
1501
10
.
53.
Ma
S
,
Vigneron
S
,
Robert
P
,
Strub
JM
,
Cianferani
S
,
Castro
A
, et al
Greatwall dephosphorylation and inactivation upon mitotic exit is triggered by PP1
.
J Cell Sci
2016
;
129
:
1329
39
.
54.
Rogers
S
,
Fey
D
,
McCloy
RA
,
Parker
BL
,
Mitchell
NJ
,
Payne
RJ
, et al
PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cells
.
J Cell Sci
2016
;
129
:
1340
54
.
55.
Winkler
C
,
De Munter
S
,
Van Dessel
N
,
Lesage
B
,
Heroes
E
,
Boens
S
, et al
The selective inhibition of protein phosphatase-1 results in mitotic catastrophe and impaired tumor growth
.
J Cell Sci
2015
;
128
:
4526
37
.